The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist.
Rimoy, G H
The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist. [electronic resource] - European journal of clinical pharmacology 1994 - 203-7 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
0031-6970
10.1007/BF00192549 doi
Adult
Blood Pressure--drug effects
Central Nervous System Agents--pharmacology
Cerebrovascular Circulation--drug effects
Diuretics--administration & dosage
Double-Blind Method
Hemodynamics--drug effects
Humans
Hypnotics and Sedatives--pharmacology
Injections, Intramuscular
Injections, Intravenous
Male
Naloxone--pharmacology
Norepinephrine--blood
Psychometrics
Pulse--drug effects
Pyrrolidines--administration & dosage
Receptors, Opioid, kappa--drug effects
The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist. [electronic resource] - European journal of clinical pharmacology 1994 - 203-7 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
0031-6970
10.1007/BF00192549 doi
Adult
Blood Pressure--drug effects
Central Nervous System Agents--pharmacology
Cerebrovascular Circulation--drug effects
Diuretics--administration & dosage
Double-Blind Method
Hemodynamics--drug effects
Humans
Hypnotics and Sedatives--pharmacology
Injections, Intramuscular
Injections, Intravenous
Male
Naloxone--pharmacology
Norepinephrine--blood
Psychometrics
Pulse--drug effects
Pyrrolidines--administration & dosage
Receptors, Opioid, kappa--drug effects